-
SARS-CoV-2 Pseudoviral Particles, BA.2.87.1 Variant
SARS-CoV-2 Pseudoviral Particles, BA.2.87.1 Variant
- 中文名称：
- SARS-CoV-2 Pseudoviral Particles, BA.2.87.1 Variant
- 英文名称：
- SARS-CoV-2 Pseudoviral Particles, BA.2.87.1 Variant
- 品牌：
- AAA Biotech
- 品牌介绍：
- AAA Biotech专注于为全球生命科学研究提供高品质的蛋白质研究工具，核心产品包括经严格验证的抗体、重组蛋白及ELISA试剂盒。
- 货号：
- AAA62266
- 规格：
- 5 mL|2x5 mL|3x5 mL|4x5 mL|5x5 mL
- 保存建议：
- Upon receiving it, store at -70 oC right away. Thaw* before immediate use. *Note: read the instruction for thawing in the following protocol carefully. Do not aliquot and refreeze. Shelf Life: Six months from the date of shipping when stored at -70 oC
- 货期：
- 6-8周
- 纯度：
- N/A
- 产品形式：
- 5 ml, for one multi-well plates; PP per mL > 1.0E+07
- 免责声明：
- *本产品仅供科研实验使用，不得用于临床诊断。*
- 说明书：
It has been known that SARS coronavirus 2 (SARS-CoV-2) uses human ACE2 as entry receptor and human proteases as entry activators. The virus surface spike protein (S) mediates SARS-CoV-2 entry into cells. To fulfill its function, SARS-CoV-2 spike binds to its human ACE2 (hACE2) receptor through its receptor-binding domain (RBD) and is proteolytically activated by human proteases.
Our SARS-CoV-2 BA.2.87.1 Pseudoviral Particles are replication-deficient MLV pseudotyped with the SARS-CoV-2 spike protein of the Omicron BA.2.87.1 variant (EPI_ISL_18849990). They also contain the ORF for firefly luciferase as a reporter. They establish a pseudovirus cell entry assay mediated by the SARS-CoV-2 spike protein that can be conveniently measured via luciferase reporter activity. This pseudovirus assay isolates the SARS-CoV-2 viral entry from other steps of the viral infection cycle.
